fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Non-antibiotic treatment for women with persistent acne shown to be effective

Written by | 21 May 2023

A team of researchers led by the University of Southampton has shown that a cheap and readily available drug, used to treat high blood pressure, could help the… read more.

Study shows promising results for immunotherapy targeting skin cancer

Written by | 28 Apr 2023

A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer. The study, published today in Nature Communications by researchers from King’s College London… read more.

Allergic (atopic) asthma/eczema linked to heightened risk of osteoarthritis

Written by | 30 Mar 2023

People with atopic (allergic) diseases like asthma or eczema may be at heightened risk of the painful and often disabling joint condition, osteoarthritis, finds research published online in… read more.

Largest study to date of lebrikizumab supports its use for treatment of atopic dermatitis

Written by | 19 Mar 2023

Two phase 3 trials suggest that a 16 week treatment with a drug called lebrikizumab was effective in adults and adolescents with moderate to severe dermatitis, according to… read more.

Study shows that bioprinted artificial skin can be used in cosmetics and drugs testing

Written by | 31 Jan 2023

Bioengineered artificial skin has become an increasingly important and reliable platform for researchers to test the safety and efficacy of drugs and cosmetics. It can be produced on… read more.

Dermatology program brings timely and accurate diagnosis of skin conditions

Written by | 27 Jan 2023

A dermatology program first developed by the University of Missouri in 2015 can bring life-saving diagnoses of skin conditions to communities without adequate dermatologic care. Researchers from the University… read more.

Simple laser treatments may help prevent nonmelanoma skin cancer

Written by | 23 Jan 2023

New research indicates that simple laser treatments to the skin may help to prevent the development of basal cell carcinoma and squamous cell carcinoma, which are collectively known… read more.

Fewer cases of melanoma among people taking vitamin D supplements

Written by | 13 Jan 2023

Fewer cases of melanoma were observed among regular users of vitamin D supplements than among non-users, a new study finds. People taking vitamin D supplements regularly also had… read more.

Scars mended using transplanted hair follicles in Imperial College London study

Written by | 9 Jan 2023

In a new study involving three volunteers, skin scars began to behave more like uninjured skin after they were treated with hair follicle transplants. The scarred skin harboured… read more.

Do skin moisturizers help prevent eczema in infants?

Written by | 24 Nov 2022

Atopic dermatitis (AD), also called atopic eczema, is the most common, chronic, recurrent, inflammatory disorder of the skin, and it affects 5–30% of children worldwide. An analysis in… read more.

Biologic dupilumab shows efficacy for eczema in young children

Written by | 29 Sep 2022

Treatment with the biologic drug dupilumab brings relief to children younger than 6 years-old who are suffering with moderate-to-severe atopic dermatitis (eczema) The findings were published on Sept…. read more.

New major survey finds ‘healthy’ suntan myths persist despite warnings about skin cancer and aging

Written by | 12 Sep 2022

(7 September 2022, Milan, Italy) 8 in 10 Europeans believe tans are attractive with almost as many (73%) saying tans are healthy, according to a new study presented… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.